Cargando…
Lysophosphatidic acid protects against acetaminophen-induced acute liver injury
We investigated the effect of lysophosphatidic acid (LPA) in experimental acetaminophen (APAP)-induced acute liver injury. LPA administration significantly reduced APAP-challenged acute liver injury, showing attenuated liver damage, liver cell death and aspartate aminotransferase and alanine aminotr...
Autores principales: | Bae, Geon Ho, Lee, Sung Kyun, Kim, Hyung Sik, Lee, Mingyu, Lee, Ha Young, Bae, Yoe-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750472/ https://www.ncbi.nlm.nih.gov/pubmed/29217823 http://dx.doi.org/10.1038/emm.2017.203 |
Ejemplares similares
-
A phospholipase D2 inhibitor, CAY10594, ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis
por: Lee, Sung Kyun, et al.
Publicado: (2019) -
VU0155069 inhibits inflammasome activation independent of phospholipase D1 activity
por: Lee, Sung Kyun, et al.
Publicado: (2019) -
Isovaleric acid ameliorates ovariectomy‐induced osteoporosis by inhibiting osteoclast differentiation
por: Cho, Kwang Min, et al.
Publicado: (2021) -
IM156, a new AMPK activator, protects against polymicrobial sepsis
por: Kang, Ji Hyeon, et al.
Publicado: (2022) -
Activation of formyl peptide receptor 2 by WKYMVm enhances emergency granulopoiesis through phospholipase C activity
por: Kim, Hyung Sik, et al.
Publicado: (2018)